English
简体中文
Total: £ 56.28
Published Date: 2025-12-04 | Pages: 86 | Tables: 87 | Medical Devices & Consumables
The global market for Clinical Irreversible Electroporation Equipment was valued at US$ 74.90 million in the year 2024 and is projected to reach a revised size of US$ 112 million by 2031, growing at a CAGR of 5.6% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Clinical Irreversible Electroporation Equipment competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Clinical Irreversible Electroporation (IRE) equipment is a high-end minimally invasive therapeutic system that delivers non-thermal tumor ablation through steep pulsed electric fields. By placing multiple needle electrodes around the lesion and delivering high-voltage short pulses, the system induces permanent nanopores in cell membranes and triggers apoptosis, achieving precise ablation while preserving the structural integrity of surrounding tissues. A typical system integrates a high-voltage pulse generator, pulse-modulation unit, multi-channel electrode interface, disposable or reusable electrode sets, imaging-guided navigation modules, and workflow-oriented surgical software. Key upstream components include high-voltage electronic modules, medical-grade alloy electrodes, insulation-coating consumables, surgical-grade metallic materials, and imaging-based localization and control software. Downstream users include oncology hospitals, interventional departments of general hospitals, cancer centers, ambulatory surgery centers, and research institutions, with applications in solid-tumor ablation, electrophysiological interventions, minimally invasive dermatological procedures, and gene/cell-level experimental studies. In 2024, global production capacity is about 400 units, with approximately 223 units sold, an average selling price of USD 336,000 per system, and a gross margin of 40%–50%. Supported by the rapid maturation of non-thermal electric-field ablation technologies and rising demand for treating tumors in challenging anatomical locations, the market continues to expand steadily.
North American market for Clinical Irreversible Electroporation Equipment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Clinical Irreversible Electroporation Equipment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Clinical Irreversible Electroporation Equipment include AngioDynamics, IGEA, Surgnova, Alpmed, Shanghai Nortion Medical Technology, Hangzhou Ready Biological Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Irreversible Electroporation Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Irreversible Electroporation Equipment.
The Clinical Irreversible Electroporation Equipment market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Irreversible Electroporation Equipment market comprehensively. Regional market sizes, concerning products by Type, by Application, by Device Grade and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Irreversible Electroporation Equipment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Device Grade and by regions.
By Company
AngioDynamics
IGEA
Surgnova
Alpmed
Shanghai Nortion Medical Technology
Hangzhou Ready Biological Technology
Segment by Type
Pulse Power Generator
Electrode Probe
Segment by Device Grade
Microsecond Level
Nanosecond Level
Segment by Tumor Types
Pancreatic Cancer
Prostate Cancer
Liver Cancer
Other
Segment by Form Factor
Mobile
Trolley-based
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Clinical Irreversible Electroporation Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Clinical Irreversible Electroporation Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Clinical Irreversible Electroporation Equipment Market Overview
1.1 Product Definition
1.2 Clinical Irreversible Electroporation Equipment by Type
1.2.1 Global Clinical Irreversible Electroporation Equipment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pulse Power Generator
1.2.3 Electrode Probe
1.3 Clinical Irreversible Electroporation Equipment by Device Grade
1.3.1 Global Clinical Irreversible Electroporation Equipment Market Value Comparison by Device Grade: 2024 VS 2031
1.3.2 Microsecond Level
1.3.3 Nanosecond Level
1.4 Clinical Irreversible Electroporation Equipment by Tumor Types
1.4.1 Global Clinical Irreversible Electroporation Equipment Market Value Comparison by Tumor Types: 2024 VS 2031
1.4.2 Pancreatic Cancer
1.4.3 Prostate Cancer
1.4.4 Liver Cancer
1.4.5 Other
1.5 Clinical Irreversible Electroporation Equipment by Form Factor
1.5.1 Global Clinical Irreversible Electroporation Equipment Market Value Comparison by Form Factor: 2024 VS 2031
1.5.2 Mobile
1.5.3 Trolley-based
1.6 Clinical Irreversible Electroporation Equipment by Application
1.6.1 Global Clinical Irreversible Electroporation Equipment Market Value by Application (2024 VS 2031)
1.6.2 Hospitals
1.6.3 Clinics
1.7 Global Clinical Irreversible Electroporation Equipment Market Size Estimates and Forecasts
1.7.1 Global Clinical Irreversible Electroporation Equipment Revenue 2020-2031
1.7.2 Global Clinical Irreversible Electroporation Equipment Sales 2020-2031
1.7.3 Global Clinical Irreversible Electroporation Equipment Market Average Price (2020-2031)
1.8 Assumptions and Limitations
2 Clinical Irreversible Electroporation Equipment Market Competition by Manufacturers
2.1 Global Clinical Irreversible Electroporation Equipment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Clinical Irreversible Electroporation Equipment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Clinical Irreversible Electroporation Equipment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Clinical Irreversible Electroporation Equipment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Clinical Irreversible Electroporation Equipment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Clinical Irreversible Electroporation Equipment, Product Type & Application
2.7 Global Key Manufacturers of Clinical Irreversible Electroporation Equipment, Date of Enter into This Industry
2.8 Global Clinical Irreversible Electroporation Equipment Market Competitive Situation and Trends
2.8.1 Global Clinical Irreversible Electroporation Equipment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Clinical Irreversible Electroporation Equipment Players Market Share by Revenue
2.8.3 Global Clinical Irreversible Electroporation Equipment Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Clinical Irreversible Electroporation Equipment Market Scenario by Region
3.1 Global Clinical Irreversible Electroporation Equipment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Clinical Irreversible Electroporation Equipment Sales by Region: 2020-2031
3.2.1 Global Clinical Irreversible Electroporation Equipment Sales by Region: 2020-2025
3.2.2 Global Clinical Irreversible Electroporation Equipment Sales by Region: 2026-2031
3.3 Global Clinical Irreversible Electroporation Equipment Revenue by Region: 2020-2031
3.3.1 Global Clinical Irreversible Electroporation Equipment Revenue by Region: 2020-2025
3.3.2 Global Clinical Irreversible Electroporation Equipment Revenue by Region: 2026-2031
3.4 North America Clinical Irreversible Electroporation Equipment Market Facts & Figures by Country
3.4.1 North America Clinical Irreversible Electroporation Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Clinical Irreversible Electroporation Equipment Sales by Country (2020-2031)
3.4.3 North America Clinical Irreversible Electroporation Equipment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Clinical Irreversible Electroporation Equipment Market Facts & Figures by Country
3.5.1 Europe Clinical Irreversible Electroporation Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Clinical Irreversible Electroporation Equipment Sales by Country (2020-2031)
3.5.3 Europe Clinical Irreversible Electroporation Equipment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Clinical Irreversible Electroporation Equipment Market Facts & Figures by Region
3.6.1 Asia Pacific Clinical Irreversible Electroporation Equipment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Clinical Irreversible Electroporation Equipment Sales by Region (2020-2031)
3.6.3 Asia Pacific Clinical Irreversible Electroporation Equipment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Clinical Irreversible Electroporation Equipment Market Facts & Figures by Country
3.7.1 Latin America Clinical Irreversible Electroporation Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Clinical Irreversible Electroporation Equipment Sales by Country (2020-2031)
3.7.3 Latin America Clinical Irreversible Electroporation Equipment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Clinical Irreversible Electroporation Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Clinical Irreversible Electroporation Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Clinical Irreversible Electroporation Equipment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Clinical Irreversible Electroporation Equipment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Clinical Irreversible Electroporation Equipment Sales by Type (2020-2031)
4.1.1 Global Clinical Irreversible Electroporation Equipment Sales by Type (2020-2025)
4.1.2 Global Clinical Irreversible Electroporation Equipment Sales by Type (2026-2031)
4.1.3 Global Clinical Irreversible Electroporation Equipment Sales Market Share by Type (2020-2031)
4.2 Global Clinical Irreversible Electroporation Equipment Revenue by Type (2020-2031)
4.2.1 Global Clinical Irreversible Electroporation Equipment Revenue by Type (2020-2025)
4.2.2 Global Clinical Irreversible Electroporation Equipment Revenue by Type (2026-2031)
4.2.3 Global Clinical Irreversible Electroporation Equipment Revenue Market Share by Type (2020-2031)
4.3 Global Clinical Irreversible Electroporation Equipment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Clinical Irreversible Electroporation Equipment Sales by Application (2020-2031)
5.1.1 Global Clinical Irreversible Electroporation Equipment Sales by Application (2020-2025)
5.1.2 Global Clinical Irreversible Electroporation Equipment Sales by Application (2026-2031)
5.1.3 Global Clinical Irreversible Electroporation Equipment Sales Market Share by Application (2020-2031)
5.2 Global Clinical Irreversible Electroporation Equipment Revenue by Application (2020-2031)
5.2.1 Global Clinical Irreversible Electroporation Equipment Revenue by Application (2020-2025)
5.2.2 Global Clinical Irreversible Electroporation Equipment Revenue by Application (2026-2031)
5.2.3 Global Clinical Irreversible Electroporation Equipment Revenue Market Share by Application (2020-2031)
5.3 Global Clinical Irreversible Electroporation Equipment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AngioDynamics
6.1.1 AngioDynamics Company Information
6.1.2 AngioDynamics Description and Business Overview
6.1.3 AngioDynamics Clinical Irreversible Electroporation Equipment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AngioDynamics Clinical Irreversible Electroporation Equipment Product Portfolio
6.1.5 AngioDynamics Recent Developments/Updates
6.2 IGEA
6.2.1 IGEA Company Information
6.2.2 IGEA Description and Business Overview
6.2.3 IGEA Clinical Irreversible Electroporation Equipment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 IGEA Clinical Irreversible Electroporation Equipment Product Portfolio
6.2.5 IGEA Recent Developments/Updates
6.3 Surgnova
6.3.1 Surgnova Company Information
6.3.2 Surgnova Description and Business Overview
6.3.3 Surgnova Clinical Irreversible Electroporation Equipment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Surgnova Clinical Irreversible Electroporation Equipment Product Portfolio
6.3.5 Surgnova Recent Developments/Updates
6.4 Alpmed
6.4.1 Alpmed Company Information
6.4.2 Alpmed Description and Business Overview
6.4.3 Alpmed Clinical Irreversible Electroporation Equipment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Alpmed Clinical Irreversible Electroporation Equipment Product Portfolio
6.4.5 Alpmed Recent Developments/Updates
6.5 Shanghai Nortion Medical Technology
6.5.1 Shanghai Nortion Medical Technology Company Information
6.5.2 Shanghai Nortion Medical Technology Description and Business Overview
6.5.3 Shanghai Nortion Medical Technology Clinical Irreversible Electroporation Equipment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shanghai Nortion Medical Technology Clinical Irreversible Electroporation Equipment Product Portfolio
6.5.5 Shanghai Nortion Medical Technology Recent Developments/Updates
6.6 Hangzhou Ready Biological Technology
6.6.1 Hangzhou Ready Biological Technology Company Information
6.6.2 Hangzhou Ready Biological Technology Description and Business Overview
6.6.3 Hangzhou Ready Biological Technology Clinical Irreversible Electroporation Equipment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hangzhou Ready Biological Technology Clinical Irreversible Electroporation Equipment Product Portfolio
6.6.5 Hangzhou Ready Biological Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Clinical Irreversible Electroporation Equipment Industry Chain Analysis
7.2 Clinical Irreversible Electroporation Equipment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Clinical Irreversible Electroporation Equipment Production Mode & Process Analysis
7.4 Clinical Irreversible Electroporation Equipment Sales and Marketing
7.4.1 Clinical Irreversible Electroporation Equipment Sales Channels
7.4.2 Clinical Irreversible Electroporation Equipment Distributors
7.5 Clinical Irreversible Electroporation Equipment Customer Analysis
8 Clinical Irreversible Electroporation Equipment Market Dynamics
8.1 Clinical Irreversible Electroporation Equipment Industry Trends
8.2 Clinical Irreversible Electroporation Equipment Market Drivers
8.3 Clinical Irreversible Electroporation Equipment Market Challenges
8.4 Clinical Irreversible Electroporation Equipment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Clinical Irreversible Electroporation Equipment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Clinical Irreversible Electroporation Equipment Market Value by Device Grade, (US$ Million) & (2024 VS 2031)
Table 3. Global Clinical Irreversible Electroporation Equipment Market Value by Tumor Types, (US$ Million) & (2024 VS 2031)
Table 4. Global Clinical Irreversible Electroporation Equipment Market Value by Form Factor, (US$ Million) & (2024 VS 2031)
Table 5. Global Clinical Irreversible Electroporation Equipment Market Value by Application (2024 VS 2031) & (US$ Million)
Table 6. Global Clinical Irreversible Electroporation Equipment Market Competitive Situation by Manufacturers in 2024
Table 7. Global Clinical Irreversible Electroporation Equipment Sales (Units) of Key Manufacturers (2020-2025)
Table 8. Global Clinical Irreversible Electroporation Equipment Sales Market Share by Manufacturers (2020-2025)
Table 9. Global Clinical Irreversible Electroporation Equipment Revenue (US$ Million) by Manufacturers (2020-2025)
Table 10. Global Clinical Irreversible Electroporation Equipment Revenue Share by Manufacturers (2020-2025)
Table 11. Global Market Clinical Irreversible Electroporation Equipment Average Price (K US$/Unit) of Key Manufacturers (2020-2025)
Table 12. Global Key Players of Clinical Irreversible Electroporation Equipment, Industry Ranking, 2022 VS 2023 VS 2024
Table 13. Global Key Manufacturers of Clinical Irreversible Electroporation Equipment, Manufacturing Sites & Headquarters
Table 14. Global Key Manufacturers of Clinical Irreversible Electroporation Equipment, Product Type & Application
Table 15. Global Key Manufacturers of Clinical Irreversible Electroporation Equipment, Date of Enter into This Industry
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Clinical Irreversible Electroporation Equipment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Irreversible Electroporation Equipment as of 2024)
Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 19. Global Clinical Irreversible Electroporation Equipment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 20. Global Clinical Irreversible Electroporation Equipment Sales by Region (2020-2025) & (Units)
Table 21. Global Clinical Irreversible Electroporation Equipment Sales Market Share by Region (2020-2025)
Table 22. Global Clinical Irreversible Electroporation Equipment Sales by Region (2026-2031) & (Units)
Table 23. Global Clinical Irreversible Electroporation Equipment Sales Market Share by Region (2026-2031)
Table 24. Global Clinical Irreversible Electroporation Equipment Revenue by Region (2020-2025) & (US$ Million)
Table 25. Global Clinical Irreversible Electroporation Equipment Revenue Market Share by Region (2020-2025)
Table 26. Global Clinical Irreversible Electroporation Equipment Revenue by Region (2026-2031) & (US$ Million)
Table 27. Global Clinical Irreversible Electroporation Equipment Revenue Market Share by Region (2026-2031)
Table 28. North America Clinical Irreversible Electroporation Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. North America Clinical Irreversible Electroporation Equipment Sales by Country (2020-2025) & (Units)
Table 30. North America Clinical Irreversible Electroporation Equipment Sales by Country (2026-2031) & (Units)
Table 31. North America Clinical Irreversible Electroporation Equipment Revenue by Country (2020-2025) & (US$ Million)
Table 32. North America Clinical Irreversible Electroporation Equipment Revenue by Country (2026-2031) & (US$ Million)
Table 33. Europe Clinical Irreversible Electroporation Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 34. Europe Clinical Irreversible Electroporation Equipment Sales by Country (2020-2025) & (Units)
Table 35. Europe Clinical Irreversible Electroporation Equipment Sales by Country (2026-2031) & (Units)
Table 36. Europe Clinical Irreversible Electroporation Equipment Revenue by Country (2020-2025) & (US$ Million)
Table 37. Europe Clinical Irreversible Electroporation Equipment Revenue by Country (2026-2031) & (US$ Million)
Table 38. Asia Pacific Clinical Irreversible Electroporation Equipment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 39. Asia Pacific Clinical Irreversible Electroporation Equipment Sales by Region (2020-2025) & (Units)
Table 40. Asia Pacific Clinical Irreversible Electroporation Equipment Sales by Region (2026-2031) & (Units)
Table 41. Asia Pacific Clinical Irreversible Electroporation Equipment Revenue by Region (2020-2025) & (US$ Million)
Table 42. Asia Pacific Clinical Irreversible Electroporation Equipment Revenue by Region (2026-2031) & (US$ Million)
Table 43. Latin America Clinical Irreversible Electroporation Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Latin America Clinical Irreversible Electroporation Equipment Sales by Country (2020-2025) & (Units)
Table 45. Latin America Clinical Irreversible Electroporation Equipment Sales by Country (2026-2031) & (Units)
Table 46. Latin America Clinical Irreversible Electroporation Equipment Revenue by Country (2020-2025) & (US$ Million)
Table 47. Latin America Clinical Irreversible Electroporation Equipment Revenue by Country (2026-2031) & (US$ Million)
Table 48. Middle East and Africa Clinical Irreversible Electroporation Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Middle East and Africa Clinical Irreversible Electroporation Equipment Sales by Country (2020-2025) & (Units)
Table 50. Middle East and Africa Clinical Irreversible Electroporation Equipment Sales by Country (2026-2031) & (Units)
Table 51. Middle East and Africa Clinical Irreversible Electroporation Equipment Revenue by Country (2020-2025) & (US$ Million)
Table 52. Middle East and Africa Clinical Irreversible Electroporation Equipment Revenue by Country (2026-2031) & (US$ Million)
Table 53. Global Clinical Irreversible Electroporation Equipment Sales (Units) by Type (2020-2025)
Table 54. Global Clinical Irreversible Electroporation Equipment Sales (Units) by Type (2026-2031)
Table 55. Global Clinical Irreversible Electroporation Equipment Sales Market Share by Type (2020-2025)
Table 56. Global Clinical Irreversible Electroporation Equipment Sales Market Share by Type (2026-2031)
Table 57. Global Clinical Irreversible Electroporation Equipment Revenue (US$ Million) by Type (2020-2025)
Table 58. Global Clinical Irreversible Electroporation Equipment Revenue (US$ Million) by Type (2026-2031)
Table 59. Global Clinical Irreversible Electroporation Equipment Revenue Market Share by Type (2020-2025)
Table 60. Global Clinical Irreversible Electroporation Equipment Revenue Market Share by Type (2026-2031)
Table 61. Global Clinical Irreversible Electroporation Equipment Price (K US$/Unit) by Type (2020-2025)
Table 62. Global Clinical Irreversible Electroporation Equipment Price (K US$/Unit) by Type (2026-2031)
Table 63. Global Clinical Irreversible Electroporation Equipment Sales (Units) by Application (2020-2025)
Table 64. Global Clinical Irreversible Electroporation Equipment Sales (Units) by Application (2026-2031)
Table 65. Global Clinical Irreversible Electroporation Equipment Sales Market Share by Application (2020-2025)
Table 66. Global Clinical Irreversible Electroporation Equipment Sales Market Share by Application (2026-2031)
Table 67. Global Clinical Irreversible Electroporation Equipment Revenue (US$ Million) by Application (2020-2025)
Table 68. Global Clinical Irreversible Electroporation Equipment Revenue (US$ Million) by Application (2026-2031)
Table 69. Global Clinical Irreversible Electroporation Equipment Revenue Market Share by Application (2020-2025)
Table 70. Global Clinical Irreversible Electroporation Equipment Revenue Market Share by Application (2026-2031)
Table 71. Global Clinical Irreversible Electroporation Equipment Price (K US$/Unit) by Application (2020-2025)
Table 72. Global Clinical Irreversible Electroporation Equipment Price (K US$/Unit) by Application (2026-2031)
Table 73. AngioDynamics Company Information
Table 74. AngioDynamics Description and Business Overview
Table 75. AngioDynamics Clinical Irreversible Electroporation Equipment Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 76. AngioDynamics Clinical Irreversible Electroporation Equipment Product
Table 77. AngioDynamics Recent Developments/Updates
Table 78. IGEA Company Information
Table 79. IGEA Description and Business Overview
Table 80. IGEA Clinical Irreversible Electroporation Equipment Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 81. IGEA Clinical Irreversible Electroporation Equipment Product
Table 82. IGEA Recent Developments/Updates
Table 83. Surgnova Company Information
Table 84. Surgnova Description and Business Overview
Table 85. Surgnova Clinical Irreversible Electroporation Equipment Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 86. Surgnova Clinical Irreversible Electroporation Equipment Product
Table 87. Surgnova Recent Developments/Updates
Table 88. Alpmed Company Information
Table 89. Alpmed Description and Business Overview
Table 90. Alpmed Clinical Irreversible Electroporation Equipment Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 91. Alpmed Clinical Irreversible Electroporation Equipment Product
Table 92. Alpmed Recent Developments/Updates
Table 93. Shanghai Nortion Medical Technology Company Information
Table 94. Shanghai Nortion Medical Technology Description and Business Overview
Table 95. Shanghai Nortion Medical Technology Clinical Irreversible Electroporation Equipment Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 96. Shanghai Nortion Medical Technology Clinical Irreversible Electroporation Equipment Product
Table 97. Shanghai Nortion Medical Technology Recent Developments/Updates
Table 98. Hangzhou Ready Biological Technology Company Information
Table 99. Hangzhou Ready Biological Technology Description and Business Overview
Table 100. Hangzhou Ready Biological Technology Clinical Irreversible Electroporation Equipment Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 101. Hangzhou Ready Biological Technology Clinical Irreversible Electroporation Equipment Product
Table 102. Hangzhou Ready Biological Technology Recent Developments/Updates
Table 103. Key Raw Materials Lists
Table 104. Raw Materials Key Suppliers Lists
Table 105. Clinical Irreversible Electroporation Equipment Distributors List
Table 106. Clinical Irreversible Electroporation Equipment Customers List
Table 107. Clinical Irreversible Electroporation Equipment Market Trends
Table 108. Clinical Irreversible Electroporation Equipment Market Drivers
Table 109. Clinical Irreversible Electroporation Equipment Market Challenges
Table 110. Clinical Irreversible Electroporation Equipment Market Restraints
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Product Picture of Clinical Irreversible Electroporation Equipment
Figure 2. Global Clinical Irreversible Electroporation Equipment Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Irreversible Electroporation Equipment Market Share by Type: 2024 & 2031
Figure 4. Pulse Power Generator Product Picture
Figure 5. Electrode Probe Product Picture
Figure 6. Global Clinical Irreversible Electroporation Equipment Market Value by Device Grade, (US$ Million) & (2020-2031)
Figure 7. Global Clinical Irreversible Electroporation Equipment Market Share by Device Grade: 2024 VS 2031
Figure 8. Microsecond Level Product Picture
Figure 9. Nanosecond Level Product Picture
Figure 10. Global Clinical Irreversible Electroporation Equipment Market Value by Tumor Types, (US$ Million) & (2020-2031)
Figure 11. Global Clinical Irreversible Electroporation Equipment Market Share by Tumor Types: 2024 VS 2031
Figure 12. Pancreatic Cancer Product Picture
Figure 13. Prostate Cancer Product Picture
Figure 14. Liver Cancer Product Picture
Figure 15. Other Product Picture
Figure 16. Global Clinical Irreversible Electroporation Equipment Market Value by Form Factor, (US$ Million) & (2020-2031)
Figure 17. Global Clinical Irreversible Electroporation Equipment Market Share by Form Factor: 2024 VS 2031
Figure 18. Mobile Product Picture
Figure 19. Trolley-based Product Picture
Figure 20. Global Clinical Irreversible Electroporation Equipment Market Value by Application (2020-2031) & (US$ Million)
Figure 21. Global Clinical Irreversible Electroporation Equipment Market Share by Application: 2024 & 2031
Figure 22. Hospitals
Figure 23. Clinics
Figure 24. Global Clinical Irreversible Electroporation Equipment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Clinical Irreversible Electroporation Equipment Market Size (2020-2031) & (US$ Million)
Figure 26. Global Clinical Irreversible Electroporation Equipment Sales (2020-2031) & (Units)
Figure 27. Global Clinical Irreversible Electroporation Equipment Average Price (K US$/Unit) & (2020-2031)
Figure 28. Clinical Irreversible Electroporation Equipment Report Years Considered
Figure 29. Clinical Irreversible Electroporation Equipment Sales Share by Manufacturers in 2024
Figure 30. Global Clinical Irreversible Electroporation Equipment Revenue Share by Manufacturers in 2024
Figure 31. Global 5 and 10 Largest Clinical Irreversible Electroporation Equipment Players: Market Share by Revenue in Clinical Irreversible Electroporation Equipment in 2024
Figure 32. Clinical Irreversible Electroporation Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 33. Global Clinical Irreversible Electroporation Equipment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 34. North America Clinical Irreversible Electroporation Equipment Sales Market Share by Country (2020-2031)
Figure 35. North America Clinical Irreversible Electroporation Equipment Revenue Market Share by Country (2020-2031)
Figure 36. United States Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Canada Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Europe Clinical Irreversible Electroporation Equipment Sales Market Share by Country (2020-2031)
Figure 39. Europe Clinical Irreversible Electroporation Equipment Revenue Market Share by Country (2020-2031)
Figure 40. Germany Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. France Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. U.K. Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Italy Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Russia Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Asia Pacific Clinical Irreversible Electroporation Equipment Sales Market Share by Region (2020-2031)
Figure 46. Asia Pacific Clinical Irreversible Electroporation Equipment Revenue Market Share by Region (2020-2031)
Figure 47. China Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Japan Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. South Korea Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. India Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Australia Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. China Taiwan Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Latin America Clinical Irreversible Electroporation Equipment Sales Market Share by Country (2020-2031)
Figure 55. Latin America Clinical Irreversible Electroporation Equipment Revenue Market Share by Country (2020-2031)
Figure 56. Mexico Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Brazil Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Argentina Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Colombia Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Clinical Irreversible Electroporation Equipment Sales Market Share by Country (2020-2031)
Figure 61. Middle East and Africa Clinical Irreversible Electroporation Equipment Revenue Market Share by Country (2020-2031)
Figure 62. Turkey Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. Saudi Arabia Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. UAE Clinical Irreversible Electroporation Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 65. Global Sales Market Share of Clinical Irreversible Electroporation Equipment by Type (2020-2031)
Figure 66. Global Revenue Market Share of Clinical Irreversible Electroporation Equipment by Type (2020-2031)
Figure 67. Global Clinical Irreversible Electroporation Equipment Price (K US$/Unit) by Type (2020-2031)
Figure 68. Global Sales Market Share of Clinical Irreversible Electroporation Equipment by Application (2020-2031)
Figure 69. Global Revenue Market Share of Clinical Irreversible Electroporation Equipment by Application (2020-2031)
Figure 70. Global Clinical Irreversible Electroporation Equipment Price (K US$/Unit) by Application (2020-2031)
Figure 71. Clinical Irreversible Electroporation Equipment Value Chain
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
